Key terms

About ACET

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ACET news

Apr 02 6:30am ET Analysts Offer Insights on Healthcare Companies: Genelux Corp. (GNLX), Adicet Bio (ACET) and Entera Bio (ENTX) by TipRanks Mar 21 9:05am ET Adicet Bio (ACET) Receives a New Rating from Truist Financial by TipRanks Mar 20 12:26pm ET Adicet Bio: A Strong Buy on Robust Financials and Promising Clinical Trials by TipRanks Mar 20 10:55am ET Buy Rating Affirmed for Adicet Bio Amid Promising CAR T-Cell Therapies and Strong Financial Footing by TipRanks Mar 20 7:25am ET Adicet Bio’s Promising Drug Pipeline and Buy Rating Justification by TipRanks Mar 20 5:56am ET Buy Recommendation for Adicet Bio Amid Promising Autoimmune and Cancer Therapy Developments by TipRanks Mar 20 12:25am ET JMP Securities Keeps Their Hold Rating on Adicet Bio (ACET) by TipRanks Mar 19 4:13pm ET Adicet Bio reports Q4 EPS (69c), consensus (69c) by TipRanks Feb 13 2:02pm ET Adicet upgraded to Buy on cell therapy potential at JonesResearch by TipRanks Feb 13 1:56pm ET Adicet Bio upgraded to Buy from Hold at JonesResearch by TipRanks Feb 02 9:34am ET Adicet Bio price target lowered to $10 from $26 at H.C. Wainwright by TipRanks Jan 25 4:36am ET Adicet Bio Announces Offering Pricing and Cash Position by TipRanks Jan 25 4:36am ET Adicet Bio Launches Public Stock and Warrant Offering by TipRanks Jan 23 6:14am ET Adicet Bio 27.05M share Spot Secondary priced at $2.40 by TipRanks Jan 22 4:30pm ET Adicet Bio announces common stock offering, no amount given by TipRanks Jan 09 4:26pm ET JMP Securities Sticks to Their Hold Rating for Adicet Bio (ACET) by TipRanks Jan 07 5:28am ET Adicet Bio (ACET) Gets a Buy from BTIG by TipRanks Jan 05 7:29am ET Adicet Bio price target lowered to $19 from $21 at Canaccord by TipRanks Jan 04 12:25pm ET Buy Rating on Adicet Bio Backed by Strong Clinical Data and Strategic Focus on MCL by TipRanks

No recent news articles are available for ACET

No recent press releases are available for ACET

ACET Financials

1-year income & revenue

Key terms

ACET Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ACET Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel